InvestorsHub Logo
Followers 5
Posts 420
Boards Moderated 0
Alias Born 04/19/2014

Re: QuidWilson post# 60005

Sunday, 10/08/2017 2:43:40 PM

Sunday, October 08, 2017 2:43:40 PM

Post# of 140475
I think Titans three choices of surgical indications that they are going for FDA approval were choices because of there simplicity in both programming the robot and learning curve for surgeons. I believe the pivotal indication in ISRGs rise to fame was prostatectomy as it pretty much eliminated sexual dis function by not impacting the nerve bundles that surround the prostate. This sealed the robots fate as the choice of most patients and from a marketing stand point hospitals needed the Da Vinci, in spite of its money loosing expenses, just to keep the patient. I am guessing that is why Dr. Patel is part of our team as once we get the FDA's blessing that prostatectomy will be one of the next indications that Titan goes for. Do you think the hospitals would be interesting in a robotic surgery platform that actually fulfills there marketing needs and allows them do these surgeries while hopefully turning a profit? Hell Yes!!